- 专利标题: Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
-
申请号: US12085880申请日: 2006-12-01
-
公开(公告)号: US08143393B2公开(公告)日: 2012-03-27
- 发明人: Julie A. Dixon , Barton Phillips , Furahi Achebe , Harold C. E. Kluender , Jason Newcom , Kyle Parcella , Steven Magnuson , Zhenqiu Hong , Zhonghua Zhang , Zheng Liu , Uday Khire , Lei Wang , Martin Michels , Brent Chandler , Stephen O'Connor
- 申请人: Julie A. Dixon , Barton Phillips , Furahi Achebe , Harold C. E. Kluender , Jason Newcom , Kyle Parcella , Steven Magnuson , Zhenqiu Hong , Zhonghua Zhang , Zheng Liu , Uday Khire , Lei Wang , Martin Michels , Brent Chandler , Stephen O'Connor
- 申请人地址: US NY Tarrytown
- 专利权人: Bayer HealthCare LLC
- 当前专利权人: Bayer HealthCare LLC
- 当前专利权人地址: US NY Tarrytown
- 代理机构: Edwards Wildman Palmer LLP
- 代理商 Barry Kramer; Nicholas J. DiCeglie, Jr.
- 国际申请: PCT/US2006/046081 WO 20061201
- 国际公布: WO2007/064931 WO 20070607
- 主分类号: C07D487/04
- IPC分类号: C07D487/04 ; C07D417/02 ; C07D413/02 ; A61K31/53 ; A61P35/00
摘要:
This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.
公开/授权文献
信息查询